River Global Investors LLP Sells 2,921 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

River Global Investors LLP cut its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 5.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 48,857 shares of the company’s stock after selling 2,921 shares during the period. River Global Investors LLP’s holdings in Bath & Body Works were worth $2,108,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Front Row Advisors LLC purchased a new position in shares of Bath & Body Works in the 3rd quarter valued at approximately $25,000. Trust Co. of Vermont bought a new stake in shares of Bath & Body Works during the 3rd quarter valued at $27,000. Denali Advisors LLC purchased a new stake in shares of Bath & Body Works in the 4th quarter worth about $27,000. GAMMA Investing LLC bought a new position in shares of Bath & Body Works in the 4th quarter worth about $27,000. Finally, Turtle Creek Wealth Advisors LLC purchased a new position in Bath & Body Works during the 4th quarter valued at about $35,000. 95.14% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the sale, the insider now directly owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.19% of the stock is currently owned by insiders.

Bath & Body Works Trading Up 4.9 %

NYSE:BBWI traded up $2.14 during trading hours on Friday, reaching $45.97. The company had a trading volume of 2,585,013 shares, compared to its average volume of 2,601,801. The firm has a market cap of $10.34 billion, a price-to-earnings ratio of 11.94, a PEG ratio of 1.42 and a beta of 1.89. The firm’s 50 day moving average price is $46.07 and its 200-day moving average price is $41.03. Bath & Body Works, Inc. has a 52 week low of $27.30 and a 52 week high of $50.34.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. The firm had revenue of $2.91 billion for the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same period last year, the business posted $1.86 EPS. On average, analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.74%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.78%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on BBWI. TD Cowen raised their target price on shares of Bath & Body Works from $35.00 to $55.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. The Goldman Sachs Group boosted their target price on Bath & Body Works from $49.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, March 4th. BMO Capital Markets raised their price target on Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Robert W. Baird upped their price target on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Finally, UBS Group increased their price objective on shares of Bath & Body Works from $46.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of “Hold” and an average price target of $46.73.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.